Next Generation Sequencing Sample Preparation Market to Witness Impressive Growth, Size to Surge to USD 6,630.0 Million by 2027 – Emergen Research
The increased advancements in NGS platforms, a decrease in the price of sequencing, and improving the NGS-based diagnostic test reimbursement scenario are driving the demand for the market.
According to a recent analysis by Emergen Research, the global market for next-generation sequencing (NGS) sample preparation is anticipated to reach USD 6,630.0 Million by 2027. One of the key aspects driving the growth of the NGS sample preparation industry is the numerous benefits of high-performance sequencing over genetics-related technologies like microarray and sanger-seq. Additionally, it is predicted that the availability of sample methods with less DNA input will lower total costs, increasing the usage of next-generation sequencing in a variety of academic and medical settings.
Due to the increasing frequency of infectious diseases around the world, the therapeutic area category for infectious diseases is anticipated to experience the quickest market growth during the forecast period. The next-generation sequencing aids in the diagnosis of serious infectious disorders, in particular those brought on by combined infections. Many different samples must be sent to labs in order to lessen the burden of infectious diseases.
Get a sample of the report https://www.emergenresearch.com/request-sample/77
This market has grown as a result of a number of factors, including the falling cost of sequencing, the availability of advanced and cost-effective NGS platforms, the expansion of NGS applications in a variety of industries, including diagnostics, agro-genomics, animal research, and drug and biomarker discovery, the rise in sequencing-intensive research, and the availability of research grants (which are driving the adoption of NGS).
A complete strategy for identifying infectious diseases may now be developed thanks to advancements in next-generation sequencing technology. New viruses and disorders that are resistant to traditional testing have been screened for and diagnosed using NGS. The method allows for universal and unbiased pathogen identification by continuously improving and recognising every pathogen that might be present in a sample. The use of NGS equipment and supplies in general, including those used for specimen preparation, has increased as a result of this.
Key participants include Agilent Technologies, Bio-Rad Laboratories, Inc., BGI; Biomatters Ltd., Congenica Ltd, Eurofins Scientific, DNASTAR, F. Hoffmann-La Roche Ltd., Genomatix GmbH, Thermo Fisher Scientific, and Foundation Medicine, among others, among others.
Emergen Research has segmented the global next generation sequencing (NGS) sample preparation market on the basis of workflow, application, end-users, and region:
Workflow Outlook (Revenue, USD Billion; 2017-2027)
- NGS Library Preparation Kit
- Semi-Automated Library Preparation
- Automated Library Preparation
- Colonial Amplification
Application Outlook (Revenue, USD Billion; 2017-2027)
- Clinical Investigation
- Reproductive Health
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology, & Drug Development
- Agrigenomics & Forensics
- Consumer Genomics
To know more about the report, visit https://www.emergenresearch.com/industry-report/next-generation-sequencing-sample-preparation-market
End-Users Outlook (Revenue, USD Billion; 2017-2027)
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Saudi Arabia
- Rest of MEA
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]